Publisher's Synopsis
Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Irbesartan Editorial: "The recent World Health Organization statement identified hypertension as one of the most important, preventable causes of death worldwide." Disease Overview: "The poor control of hypertension appears to be the result of poor detection and awareness of the condition, coupled with inadequate treatment." Drug Review: "Irbesartan is a selective and potent AT1-receptor antagonist, which produces greater functional antagonism of AT II than other agents in its class." Improving Practice: "Primary care still bears the responsibility for implementing best practice and must respond by developing new strategies to deliver enhanced, focused and appropriate care for our hypertensive patients."
